CIK 0001898496 · <br>Emerging growth company
Getty Images Holdings, Inc.
Sign in to watch- Ticker
- GETYQ
- Exchange
- OTC
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (206) 925-5000
- Business address
- 605 5TH AVENUE S., SUITE 400, SEATTLE, WA, 98104
- Former names
- VECTOR HOLDING, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $588
- in 1 filing
Net −$588. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Kellough Kjelti Wilkes General Counsel | Grant or award | +250,000 | 538,583 | ||
| 2026-03-31 | Orlowsky Peter Senior Vice President | Grant or award | +250,000 | 502,890 | ||
| 2026-03-31 | Gandert Nathaniel Chief Technology Officer | Grant or award | +250,000 | 840,242 | ||
| 2026-03-31 | Farhall Grant Chief Product Officer | Grant or award | +250,000 | 538,190 | ||
| 2026-03-31 | Leyden Jennifer Chief Financial Officer | Grant or award | +250,000 | 566,780 | ||
| 2026-03-31 | Foca Gene Chief Marketing Officer | Grant or award | +250,000 | 757,651 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −106,366 | 0 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −53,514 | 0 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −25,579 | 0 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −319,761 | 0 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Grant or award · Stock Option (Right to Buy) | +70,908 | 70,908 | ||
| 2026-03-27 | Orlowsky Peter Senior Vice President | Grant or award · Stock Option (Right to Buy) | +52,471 | 52,471 | ||
| 2026-03-27 | Foca Gene Chief Marketing Officer | Returned to the company · Stock Option (Right to Buy) | −639,523 | 0 | ||
| 2026-03-27 | Foca Gene Chief Marketing Officer | Returned to the company · Stock Option (Right to Buy) | −1,029,047 | 0 | ||
| 2026-03-27 | Foca Gene Chief Marketing Officer | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | ||
| 2026-03-27 | Foca Gene Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +219,776 | 219,776 | ||
| 2026-03-27 | Foca Gene Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +131,777 | 131,177 | ||
| 2026-03-27 | Teaster Michael Chief of Staff | Returned to the company · Stock Option (Right to Buy) | −132,901 | 0 | ||
| 2026-03-27 | Teaster Michael Chief of Staff | Returned to the company · Stock Option (Right to Buy) | −295,677 | 0 |
Page 3 of 14 · 266 trades